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Abstrak
Nikotin, senyawa utama dalam rokok, merupakan senyawa yang dianggap paling bertanggung jawab 
pada ketergantungan rokok. Kecepatan metabolisme nikotin diduga merupakan salah satu faktor 
yang menentukan jumlah rokok yang dihisap oleh seorang perokok. Oleh karena itu, jumlah rokok 
yang dihisap oleh seorang pemetabolisme cepat akan lebih banyak dibanding dengan pemetabolisme 
lambat. Nikotin dalam tubuh akan dimetabolisme oleh enzim sitokrom P450 2A6 menjadi kotinin, dimana 
kotinin selanjutnya akan diubah menjadi 3’-hidroksikotinin. Rasio 3’-hidroksikotinin terhadap kotinin 
(3OH-Cot/Cot) menunjukkan aktifitas sitokrom P450 2A6. Rasio 3OH-Cot/Cot dari 50 urin sampel 
perokok ditentukan dengan metode Kromatografi Cair Kinerja Tinggi HPLC menggunakan kolom C8 
fully endcapped residual silanol, detektor UV serta menggunakan ekstraksi cair-cair. Semua subjek 
uji yang terlibat pada penelitian ini telah diidentifikasi mempunyai genotipe CYP2A6*1/*4. Aktivitas 
enzim CYP2A6 yang ditunjukkan dengan rasio 3OH-Cot/Cot pada penelitian ini berada pada rentang 
0,10-0,93. Sebanyak 84% subjek uji teridentifikasi sebagai slow metaboliser dan hanya sebanyak 16% 
subyek uji yang teridentifikasi sebagai fast metaboliser. Terdapat hubungan yang positif antara rasio 
3OH-Cot/Cot dengan jumlah rokok yang dihisap perhari (r = 0,327, p = 0,020). Hasil penelitian ini 
mendukung hipotesis yang menyatakan bahwa kecepatan metabolisme nikotin merupakan salah satu 
yang menentukan jumlah rokok yang dihisap oleh seorang perokok serta mendukung penggunaan rasio 
3OH-Cot/Cot sebagai penanda kecepatan metabolisme nikotin.
Kata kunci: nikotin, kotinin, trans-3′-Hidroksikotinin, Sitokrom P450 2A6  
Abstract
Nicotine, the active compound on cigarette,was a compound that responsible to smoking addiction. The 
rate of nicotine metabolism is hypothesized to be a determinant of how much a person smokes. That is, 
rapid metabolizers would be expected to smoke more than slow metabolizers. Nicotine is metabolized 
extensively by the liver enzyme cytochrome P450 2A6, primarily to cotinine. Cotinine then metabolized 
by cytochrome P450 2A6 to 3’-hydroxycotinine. The ratio of metabolite to parent (i.e., 3OH-Cot/Cot) 
would be expected to reflect CYP2A6 activity. The ratio of 3OH-Cot/Cot in the 50 urine smokers was 
measured by HPLC method with an C8 fully endcapped residual silanol-type column coupled and UV 
detection with liquid-liquid extraction. All of the subject had been genotyped as CYP2A6*1/*4. Upon 
completion of the study, the CYP2A6 activity determined by ratio 3OH-Cot/Cot were between 0.01-0.93. 
There were 84% of subject identified as slow metabolizer and only 16% of subject identified as fast 
metabolizer.The ratio of 3OH-Cot/Cot was positively correlated with the number of cigarettes smoked 
per day (r = 0.327, p = 0.020). This finding supports the hypothesis that the rate of nicotine metabolism 
is a determinant of the level of cigarette consumption and supports the use of the 3OH-Cot/Cot ratio as 
a non-invasive marker of nicotine metabolism.
Keywords: nicotine; cotinine; trans-3′-Hydroxycotinine; Cytochrome P450 2A6  
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Introduction 
 Tobacco consumption kills at least 
200,000 people annually in Indonesia, and 
tobacco use has serious negative health impacts 
for nearly every organ in the body. Although 
smoking has been clearly identified as a direct 
cause of multiple medical disorders, including 
cancers, cardiovascular, and respiratory diseases, 
people continue to smoke. Nearly all (97%) 
tobacco users in Indonesia smoke cigarettes. 
Smokers are predominantly male, although the 
prevalence of female smoking is increasing. 
Smoking prevalence is 34%, and 63% of men 
smoke.1 Cigarette consumption in Indonesia is 
number fourth in the world; after China, USA and 
Russia. Community Based Surveys, Global  Adult 
Tobacco  Survey  (GATS) Indonesia  2011, shows 
significant  increase  of  active  male  cigarette 
smokers in Indonesia, that is from 53.9% in 1995 
to 67.0% in 2011. The smoker is more prevalent 
in male (67.0%) as compared to female (2.7%).2
 Nicotine is of importance as the addictive 
chemical in tobacco, pharmacotherapy for 
smoking cessation and a useful probe drug for 
phenotyping cytochrome P450 2A6 (CYP2A6).3 
The plasma concentration of nicotine varies 
among tobacco users, due in part to differences 
in nicotine metabolism. An important route of 
nicotine metabolism involves cytochrome P450 
(CYP) 2A6 / aldehyde oxidase (AO) - mediated 
conversion to cotinine (Cot). This is thought to be 
followed by further CYP2A6-mediated  oxidation 
of Cot to trans-3´-hydroxycotinine (3OH-Cot)4 
(Figure 1). 
 Since the conversion of Cot to 3OH-
Cot entirely due to CYP2A6 activity, the ratio 
of 3OH-Cot to Cot (referred to as the nicotine 
metabolite ratio or NMR),  provides a convenient 
measure to phenotype individuals for CYP2A6 
activity and could serve as a marker for nicotine 
metabolism rate.5 This method is being used for 
large-scale pharmacogenetic studies. Metabolic 
activation of some carcinogenic nitrosamines, 
including some present in tobacco, is mediated by 
CYP2A6,6–9 and that is another reason for interest 
in this phenotypic marker.
 Nicotine metabolism by cytochrome 
P450 2A6 (CYP2A6) varies across ethnicity/
race and is hypothesized to affect smoking 
behavior.10–12 The NMR in the urine of young 
adult smokers was higher in whites and Hispanics 
than in blacks and Asians.13
 Cot and 3OH-Cot have relatively longer 
half-life than nicotine and it can be easily detected 
in urine, serum, plasma and saliva. The 3OH-
Cot concentrations in urine generally exceed 
Cot concentrations by 3-4 fold, consequently, 
determination of 3OH-Cot, as well as Cot, might 
provide a more sensitive measure of exposure, 
especially when urine is used.14–17 In the present 
study, we describe a simple HPLC method using an 
C8 fully endcapped residual silanol-type column 
coupled with UV detection for determination of 
Cot and 3OH-Cot in human urine with liquid-
liquid extraction. According to a previously 
published procedure, it was not easy to eluate Cot 
from HPLC in a short time.18 This method can 
easily resolve Cot from 3OH-Cot and acetanilide 
(Internal Standard) in a short period of 10 min 
and serves as a useful tool for the assessment of 
the 3OH-Cot/Cot ratio. Since CYP2A6 has been 
identified as the enzyme that responsibles for 
the clearance of many drugs and environmental 
chemicals, in this study, the activity of CYP2A6 
is investigated in Javanese Indonesian smoker. 
The objectives of this study were to determine the 
enzyme CYP2A6 activity in Indonesian smokers 
using the NMR as phenotype of these enzyme.
Figure. 1. Metabolism of Nicotine to Cotinine and Trans-3-Hydroxycotinine.4
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Method
 Cotinine and trans-3-hydroxycotinine 
were provided by Sigma Chemical Co., St. Louis 
and Santa Cruz Biotechnology Inc. Acetanilide 
as internal standard was an analytical grade 
obtained from Merck, Darmstadt Germany. 
HPLC grade methanol was; obtained from Fisher 
Scientific, UK., sodium hydroxide, chloroform 
and ethanol used were of analytical grade (J. T. 
Baker Chemical Co., Phillipsburg, NJ.), water 
purification system was used to obtain the purified 
water for the HPLC analysis.
 The instruments used were: 
a. HPLC systems. A Shimadzu (Kyoto, Japan) 
HPLC system was used consisting of a LC 
2010HT system controller equipped with 
two LC-8A pumps, an UV detector (SPD-
20A/20AV) (Shimadzu Corporation, Kyoto, 
Japan) and a high throughput autosampler 
injector. The detector was set at 260 nm at a 
sensitivity of 0.0001 AUFS.
b. Columns. Chromatographic separation was 
achieved with a Premier C8 fully endcapped 
residual silanol column (5µm, 4,6x250 
mm, Shimadzu, Kyoto, Japan) at room 
temperature.
c. Software. The data were acquired and 
processed using LC solution (Version 1.03 
SP3, Shimadzu Corporation, Kyoto, Japan) 
software running under Windows XP on a 
Pentium PC. 
 Chromatographic separation was 
achieved with a Premier C8 fully endcapped 
residual silanol column at room temperature 
(25oC). The mobile phase consisted of metanol 
and amonium asetat 5 mM (50 : 50) at a flow rate 
of 1.0 ml/min. The samples were kept at room 
temperature (25oC) and a volume of 20 µl was 
injected for analysis. Ultraviolet detection was 
achieved with a SPD-20A/20AV UV-VIS detector 
at 260 nm at a sensitivity of 0.0001 AUFS. The 
total run time was 8 minutes.
 To determine cotinine and trans-3 
Hydroxycotinine in urine samples from male 
smokers, the study had been done on 2012 and 
had been approved by the Ethics Committees 
of Medical Research Gadjah Mada University 
(Yogyakarta, Indonesia). A total of 50 male 
healthy Javanese Indonesian smokers were 
recruited from students and staffs of Sanata 
Dharma University. They were asked to provide 
information on the numbers of cigarettes smoked 
daily (Table 1). The  smokers  were  selected 
according to their smoking habits which were 
categorized into three levels: light smokers 
(CPD: 1-10), intermediate smokers (CPD: 11-
20) and heavy smokers (CPD: 21-30).19 Smoking 
status was assigned based on questionnaires, 
which requested information on smoking history, 
such as the number of cigarettes per day (CPD), 
the nicotine content of the cigarettes, which they 
usually smoke, and time to the first cigarette of 
the day, which is generally accepted as a clinical 
index for nicotine dependence.20 The subject 
had smoked for minimum 1 year, not currently 
planning to stop smoking, between 18 and 50 
years-old, took no concurrent medications, 
and had no illnesses requiring investigation or 
treatment. Urine samples were obtained from 
test individuals by collecting the first urine in 
the morning (5-15 mL) and were kept frozen at 
-20°C in polypropylene bottles until analysed (1 
month).  
 Urinary Cot and 3OH-Cot were extracted 
and prepared for HPLC analysis as described by 
Patramurti et al.21 The samples of the first urine 
in the morning of 50 smokers were separately 
collected. Quantification of Cot and 3OH-Cot 
were done by plotting Cot and 3OH-Cot to 
internal standard (acetanilide) peak area ratio as a 
function of acetanilide concentration. The urinary 
NMR was determined using the formula: 
                                
 The distribution of the NMR among 
subjects was tested for normality using 
Kolmogorov–Smirnov test. One Way Anova 
followed by Tukey multiple comparison test was 
used to determine differences in NMR by smoker 
groups. Pearson’s correlation analysis was also 
conducted to determine whether NMR was 
related to CPD. 
Results 
 We previously reported simultaneous 
analysis of Cot and 3OH-Cot using HPLC-
UV. According to these previously published 
method, Cot, 3OH-Cot, and Acetanilide in spiked 
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samples, were eluted rapidly with a complete 
resolution and sharp symmetrical peaks. The total 
chromatographic run time for nicotine biomarkers 
in meconium was 8 minutes. Resolution times 
of 3OH-Cot, Cot, and asetanilide as internal 
standard were 3.966, 4.658 and 6.967 minutes, 
respectively.21 
 The calibration curves for 3OH-Cot and 
Cot were linear within the range from 1-5 µg/
mL for 3OH-Cot and 2-10 µg/mL for Cot with 
correlation coefficients of 0.998 and 0.998. 
Relative recoveries for both 3OH-Cot and Cot 
were 82-93% for 3OH-Cot (at 1,3 and 5 µg/mL) 
and  between 82-98% for Cot (at 2, 6, and 10 µg/
mL). Both the intra- and inter-day RSD were less 
than 10% over the range 1-5 µg/mL for 3OH-Cot 
and 2-10 µg/mL for Cot. The LOQ for the assay 
was 0.4 µg/mL for 3OH-Cot and 0.75 µg/mL for 
Cot with intra-day RSD of 11.14 and 11.52%, 
respectively, and inter-day RSD of 13.79 and 
15.82%, respectively. The LOD was 0.1 µg/mL 
for 3OH-Cot and 0.2 µg/mL for Cot. 
 The liquid-liquid extraction HPLC-
UV assay for the simultaneous detection of 
Cot, and 3OH-Cot concentrations in the urine 
Javanese Indonesian smokers was sensitive and 
reproducible; the between-day variations were 
within acceptable limits; and the assay remained 
linear in excess of the necessary ranges of 
detection. Therefore, the liquid-liquid extraction 
HPLC-UV assay can be used to identify and 
quantify levels of Cot as well as 3OH-Cot in the 
urine smokers.
 The described HPLC method was 
applied to determine NMR urine samples of 
male smokers to describe CYP2A6 activity. 
Nicotine have been used as an in vivo probe for 
CYP2A6,22–24 based on their preferential catalysis 
of different steps in the metabolism of nicotine. 
Urine NMR is more biologically reasonable to 
measure CYP2A6 activity since it incorporates 
all 3OH-Cot generated from cotinine.22 In this 
study, using NMR, the distribution of CYP2A6 
activity in 50 volunteers, aged 18 to 47, in the 
Javanese Indonesian was investigated. The 50 
smokers recruited had an average age of 35 
(SD=9) years, and an average age at which they 
had started to smoke regularly of 16 (SD=3.4) 
years. All of the subjects smoked filter cigarettes. 
A great inter-individual variation of CYP2A6 
activity, determine by NMR in the 24 hour urine 
sample, was observed with a range from 0.10 to 
0.93. The coefficient of variation of CYP2A6 
activity in this population was 34.0%. The mean 
of CYP2A6 activities among three groups of 
smokers, measured by the urinary NMR, ranged 
from 0.28 to 0.45, and the distributions of NMR 
were normal (Table 1). 
 The mean CYP2A6 activities among 
subjects, measured by the urinary NMR, were 
found to be significantly higher among heavy 
smokers vs. light smokers (p value 0.015 < 0.05) 
and heavy smokers vs. intermediate smokers (p 
value 0.017 < 0.05). 
 No statistically significant differences in 
NMR were seen among light and intermediate 
smokers (p value 1.000 > 0.05). 
 
Characteristics 
Smoking Habits 
Total
Light Intermediate Heavy
Number of subjects 19 17 14 50
Age
Mean ± SD 33.6 ± 9.1 34.94 ± 9.56 36.07 ± 8.78 34.74 ± 9.05
Range 18-45 18-46 22-47 18-47
CPD
Mean ± SD 8.15 ± 9.11 13.06 ± 1.03 22.69 ± 0.95 13.56 ± 5.98
Range 6-10 12-14 21-24 6-24
NMR
Mean ± SD 0.28 ± 0.14 0.28 ± 0.16 0.45 ± 0.21 0.33 ± 0.18
Range 0.10-0.67 0.11-0.73 0.19-0.93 0.10-0.93
Table 1. Demographic Characteristics of Subjects According to Smoking Habits and CYP2A6 
              Activity Measured by the Urinary NMR
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Discussion
 This is the first study examining the 
relationship between CYP2A6 activity and 
smoking behaviors in Javanese Indonesian 
smokers. Inter-individual differences in the 
activity of drug metabolizing enzymes are of 
great importance in drug treatment. People 
with significant difference in drug metabolizing 
enzyme activity are at higher risk of drug toxicity 
or poor therapeutic outcome. Cytochrome 
P450 enzymes are especially important in this 
respect, as they are responsible for the most 
reactions of drug metabolism. As some important 
carcinogens such as aflatoxin B1 and nitosamines 
are metabolized by CYP2A6,25 the lower activity 
of CYP2A6 in Javanese population poses them 
to a lower risk of cancer incidence due to active 
metabolites of these compounds. This may also 
be important in the metabolism and half-life of 
its drug substrates such as halothane and valproic 
acid. 
 The NMR, derived from urinary 
measures of cotinine and 3-hydroxycotinine, 
has been shown previously to correlate with 
the amount of cigarette consumption during ad 
libitum smoking,5 suggesting that rates of nicotine 
 
metabolism and clearance, at least in part, affect 
the amount smoked.26,27 In the present study, we 
found a positive correlation between the urine 
NMR and CPD in adult smokers, which indicates 
that faster nicotine metabolism increases smoking 
rates (Figure 2). The correlation between NMR 
and CPD among the smokers was also significant, 
but of low predictive value (r = 0.375, p = 0.02). 
We speculated that the low of relation between 
the NMR and CPD is associated with the 
relatively low level of smoking (average CPD = 
13) among our subjects, who may not have been 
as nicotine dependent. Social reasons and the 
social environment play a role in smoking uptake, 
smoking maintenance and smoking Cessation.28
 The disposition of Cot to 3OH-Cot, 
similarly to the metabolism of nicotine to Cot, is 
CYP2A6 mediated and has been shown to drive 
cigarette consumption for nicotine level self-
regulation. Faster nicotine metabolism leads to 
smoking more cigarettes is that heavier smoking 
results in higher 3OH-Cot/Cot ratios because 
of induction of nicotine metabolism.5 That is, 
heavy smokers metabolize nicotine primarily 
by pathways other than C-oxidation to cotinine, 
resulting in attenuation of the relationship 
Figure 2. Relationship between Urinary 3OH-Cot/Cot Ratios and the CPD Smoked During the 24 
                 Hours before Urine Sampling. Pearson Correlation=0.375; P=0.020.
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between 3OH-Cot/Cot ratios and the number of 
cigarettes smoked. 
 This finding supports the hypothesis that 
the rate of nicotine metabolism is associated with 
the level of cigarette consumption. Benowitz, 
et al.5 showed a correlation coefficient of 0.32 
between the 3OH-Cot/Cot ratios and the CPD 
among smokers. This value is very similar to 
those determined in our study, i.e., 0.375 for 
Pearson Correlation. The NMR, derived from 
urinary measures of Cot and 3OH-Cot, in line 
with previously study,5,27,29 are correlate with 
CPD, suggesting that rates of nicotine metabolism 
and clearance, at least in part, affect the amount 
smoked. Thus, inter-individual variability in 
nicotine metabolism appears to be an important 
factor that limits the quantitative application of 
3OH-Cot/Cot ratios as a phenotypic measure of 
CYP2A6 activity.
Conclusion
 The HPLC method using an C8 fully 
end capped residual silano-type column coupled 
with UV detection used in this research showed 
an adequate method for determination of Cot 
and 3OH-Cot in human urine. Our findings 
support the hypothesis that inter-individually 
based differences in nicotine metabolism among 
adolescent smokers are associated with the 
phenotypic expression of CYP2A6. This study 
provides further evidence that the NMR can serve 
as a phenotype marker of CYP2A6 activity. 
Suggestions
 The findings of this study provide evidence 
that among these sample study are more likely 
to be slower nicotine metabolizers. However, to 
evaluate the inter-individuals differences in the 
CYP2A6 activity in relation to polymorphisms 
of these enzymes among Javanese Indonesian 
smokers and the real effect of CYP2A6 gene 
defect on addiction to tobacco smoke, further 
studies that more precisely address smoking 
addictive behavior, tobacco consumption and 
current smoke intake via measurement of valid 
other biomarkers such as CO-hemoglobin and 
cotinine will be studied in the future. 
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